Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BioHealx® Anal Fistula Device Post Market Surveillance Study

NCT: NCT07021742 · RECRUITING

NCT IDNCT07021742
StatusRECRUITING
Start Date2025-06-14
SponsorSignum Surgical USA Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑